Table 1.
Analysis of snc886-3p abundance in PrCa microRNA datasets.
| GEO ACC * | PUBMED ID | Platform | Total Samples | Benign | Cancer | Fold Change (N/B vs T) | p-Value | Analytical Tool |
|---|---|---|---|---|---|---|---|---|
| GSE45604 | 24518785 | Affymetrix | 60 | 10 Normal | 50 Cancer | −1.4 | 0.05 | GEO2R |
| GSE26964 | 21647377 | Capitalbio | 13 | 6 Primary PrCa | 7 Metastasis Bone | −2.7 | N.S. | GEO2R |
| GSE23022 | 21400514 | Affymetrix | 40 | 20 Normal | 20 Cancer | −1.3 | 0.03 | GEO2R |
| GSE55323 | 24967583 | Agilent | 40 | 20 Non-Recurrent | 20 Recurrent | −1.2 | N.S. | GEO2R |
| GSE62610 | 25416653 | Taqman qPCR | 36 | 14 Non-Recurrent | 22 Recurrent | −1.7 | N.S. | GEO2R |
| GSE21036 | 20579941 | Agilent | 140 | 28 Normal | 112 Cancer | −2.0 | 0.001 | GEO2R |
| GSE36802 | 23233736 | Affymetrix | 42 | 21 Benign | 21 Cancer | −1.8 | 0.0002 | GEO2R |
| TCGA data | 26544944 | Small-RNA-Seq | 24 a | 12 Normal | 12 Cancer | −3.2 | 0.03 | miRDeep2 |
* GEO accession number; a PRAD-TCGA paired normal/tumor samples (52) with at least 2 reads for sdnc886-3p in normal tissue (24), paired t-test; N.S. non-significant.